ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176323; 2) Community: the network communities that were significantly associated with the response to NSC 176323; 3) Molecule: the relationships between components within communities and NSC 176323; 4) MDR: the compounds that were significantly associated with the NSC 176323.

NSC Compound Enrichment Correlation
NSC 657321 1,9-Dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone, 8,16-bis(2-oxopropyl)-, [8S-(3E,8R*,11E,16R*)]- 0.0286383688883667 -0.049143248
NSC 670558 Null 0.0286383688883667 -0.047676495
NSC 692587 ethyl-8-(4-chlorophenyl)-4-methyl-2-oxo-6-(thiophen-2-yl)-4a,7-dihydro-2H-chromene-3- carboxylate 0.0286383688883667 0.14513404
NSC 716679 Null 0.0286383688883667 0.18087111
NSC 116787 ACOVENOSIDE A 0.0286383688883668 0.37900808
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0286383688883668 0.26580116
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0286383688883668 0.14885735
NSC 404027 Null 0.0286383688883668 0.081384062
NSC 56902 Null 0.0286383688883668 0.37001803
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0286383688883668 0.13737039
Total:54  Current:33    [First] [Prev] [Next] [Last]